html Omega-3 scientific library | 180 references and studies
Content based on scientific studies and verifiable data.Updated: September 2026
Scientific library

180 studies, cohorts, trials, meta-analyses and reviews.

A navigable scientific database for directly checking the evidence used on the Omega-3 Science pages. Links open PubMed or DOI in a new tab.

180 linked references174 PubMed9 areas
What does PMID mean? It is a study identifier in PubMed, the bibliographic database of the U.S. National Library of Medicine. Click the title or PMID to open the original scientific record.

Omega-3 Index, ratio and biomarkers

Practical application: Omega-3 Index and omega-6:3 ratio.

Biomarker studies, cohorts and relationships with outcomes.

  1. Harris WS, von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med. 2004;39(1):212-220. doi:10.1016/j.ypmed.2004.02.030. PMID:15208005
  2. Ostermann AI, West AL, Schoenfeld K, et al. Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans. Am J Clin Nutr. 2019;109(5):1251-1263. doi:10.1093/ajcn/nqz016. PMID:31006007
  3. Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr. 2011;93(5):950-962. doi:10.3945/ajcn.110.006643. PMID:21367944
  4. Stark KD, Van Elswyk ME, Higgins MR, Weatherford CA, Salem N Jr. Global survey of the omega-3 fatty acids, DHA and EPA in the blood stream of healthy adults. Prog Lipid Res. 2016;63:132-152. doi:10.1016/ j.plipres.2016.05.001. PMID:27216485
  5. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56(8):365-379. doi:10.1016/S0753-3322(02)00253-6. PMID:12442909
  6. Zhang Y, Sun Y, Yu Q, et al. Higher ratio of plasma omega-6/omega-3 fatty acids is associated with greater risk of all-cause, cancer, and cardiovascular mortality: a population-based cohort study in UK Biobank. eLife. 2024;12:RP90132. doi:10.7554/eLife.90132. PMID:38578269
  7. Harris WS, Tintle NL, Etherton MR, Vasan RS. Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart Study. J Clin Lipidol. 2018;12(3):718-727.e6. doi:10.1016/j.jacl.2018.02.010. PMID:29559306

Chemical form, absorption, bioavailability and oxidation

Practical application: how to choose and how to buy a better omega-3.

TG/rTG, EE, emulsification, incorporation and oxidative quality.

  1. Dyerberg J, Madsen P, Møller JM, Aardestrup I, Schmidt EB. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot Essent Fatty Acids. 2010;83(3):137-141. doi:10.1016/j.plefa.2010.06.007. PMID:20638827
  2. Neubronner J, Schuchardt JP, Kressel G, Merkel M, von Schacky C, Hahn A. Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from re-esterified triglycerides versus ethyl esters. Eur J Clin Nutr. 2011;65(2):247-254. PMID:21063431
  3. Minton ST, et al. Comparative membrane incorporation of omega-3 fish oil formulations with different re- esterified triglyceride content. Nutrients. 2023;15. PMID:36706088
  4. Schuchardt JP, Schneider I, Meyer H, Neubronner J, von Schacky C, Hahn A. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 formulations. Lipids Health Dis. 2011;10:145. doi:10.1186/1476-511X-10-145. PMID:21854650
  5. Lawson LD, Hughes BG. Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters. Biochem Biophys Res Commun. 1988;152(1):328-335. PMID:2847723
  6. Garaiova I, Guschina IA, Plummer SF, Tang J, Wang D, Plummer NT. A randomised cross-over trial in healthy adults indicating improved absorption of omega-3 fatty acids by pre-emulsification. Nutr J. 2007;6:4. doi:10.1186/1475-2891-6-4.
  7. Raatz SK, Johnson LK, Rosenberger TA, Picklo MJ. Enhanced bioavailability of EPA from emulsified fish oil preparations versus capsules. Prostaglandins Leukot Essent Fatty Acids. 2016;113:15-21. PMID:26688435
  8. Bremmell KE, et al. A self-emulsifying omega-3 ethyl ester formulation improves EPA and DHA bioavailability. Eur J Clin Nutr. 2020;74:423-430. PMID:31637467
  9. Albert BB, Derraik JGB, Cameron-Smith D, et al. Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA. Sci Rep. 2015;5:7928. doi:10.1038/srep07928.
  10. Jackowski SA, Alvi AZ, Mirajkar A, et al. Oxidation levels of North American over-the-counter n-3 supplements and the influence of supplement formulation and delivery form. J Nutr Sci. 2015;4:e30. doi:10.1017/jns.2015.21. PMID:26688721
  11. Ottestad I, Vogt G, Retterstøl K, et al. Oxidised fish oil does not influence established markers of oxidative stress in healthy human subjects: a randomised controlled trial. Br J Nutr. 2012;108(2):315-326. PMID:22136711
  12. Albert BB, Cameron-Smith D, Hofman PL, Cutfield WS. Oxidation of marine omega-3 supplements and human health. Biomed Res Int. 2013;2013:464921. doi:10.1155/2013/464921. PMID:23738326
  13. Suzukawa M, Abbey M, Howe PR, Nestel PJ. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J Lipid Res. 1995;36(3):473-484. PMID:7775859
  14. Pedersen H, Petersen M, Major-Pedersen A, et al. Influence of fish oil supplementation on in vivo and in vitro oxidation susceptibility of LDL. Free Radic Res. 2003;37(6):647-655. PMID:12771973
  15. Brude IR, Drevon CA, Hjermann I, et al. Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants. Arterioscler Thromb Vasc Biol. 1997;17(11):2576-2588. PMID:9409230
  16. Flock MR, Skulas-Ray AC, Harris WS, et al. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation. Am J Clin Nutr. 2013;97(4):808-817. PMID:23426033
  17. Walker RE, Jackson KH, Tintle NL, Shearer GC, Bernasconi A, Masson S, Latini R, Heydari B, Kwong RY, Flock M, Kris-Etherton PM, Harris WS. Predicting the effects of supplemental EPA and DHA on the Omega-3 Index. Am J Clin Nutr. 2019;110(4):1034-1040. doi:10.1093/ajcn/nqz161. PMID:31396625

Chronic low-grade inflammation

Practical application: chronic low-grade inflammation.

Inflammatory mechanisms, resolution, cytokines, ageing and mortality.

  1. Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822-1832. doi:10.1038/s41591-019-0675-0.
  2. Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Hwang BS, Glaser R. Omega-3 supplementati‐ on lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial. Brain Behav Immun. 2012;26(6):988-995. doi:10.1016/j.bbi.2012.05.011. PMID:22640930
  3. Tan A, Sullenbarger B, Prakash R, McDaniel JC. Supplementation with eicosapentaenoic acid and docosahexaenoic acid reduces high levels of circulating proinflammatory cytokines in aging adults: a randomized, controlled study. Prostaglandins Leukot Essent Fatty Acids. 2018;132:23-29. PMID:29735019
  4. Lai HTM, de Oliveira Otto MC, Lemaitre RN, et al. Serial circulating omega 3 polyunsaturated fatty acids and healthy ageing among older adults in the Cardiovascular Health Study: prospective cohort study. BMJ. 2018;363:k4067. doi:10.1136/bmj.k4067. PMID:30333104
  5. Bischoff-Ferrari HA, Gängler S, Wieczorek M, et al. Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial. Nat Aging. 2025;5(3):376-385. doi:10.1038/s43587-024-00793-y. PMID:39900648
  6. Harris WS, Tintle NL, Imamura F, et al. Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies. Nat Commun. 2021;12:2329. doi:10.1038/s41467-021-22370-2. PMID:33888689
  7. McBurney MI, Tintle NL, Vasan RS, Sala-Vila A, Harris WS. Using an erythrocyte fatty acid fingerprint to predict risk of all-cause mortality: the Framingham Offspring Cohort. Am J Clin Nutr. 2021;114(4):1447-1454. doi:10.1093/ajcn/nqab195. PMID:34134132
  8. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases.
  9. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.
  10. Lawrence T. The nuclear factor NF-κB pathway in inflammation.
  11. Furman D, et al. Chronic inflammation in the etiology of disease across the life span.
  12. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention.

Heart and circulation

Practical application: omega-3 and heart.

Trials, cohorts, meta-analyses and cardiovascular outcomes.

  1. Flock MR, Skulas-Ray AC, Harris WS, et al. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial. J Am Heart Assoc. 2013;2(6):e000513. doi:10.1161/JAHA.113.000513. PMID:24252845
  2. Simmonds LA, Sullivan TR, Skubisz M, et al. Omega-3 fatty acid supplementation in pregnancy-baseline omega-3 status and early preterm birth: exploratory analysis of a randomised controlled trial. BJOG. 2020;127(8):975-981. doi:10.1111/1471-0528.16168. PMID:32034969
  3. Jiang H, Wang L, Wang D, et al. Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality. Clin Nutr. 2022;41(8):1798-1808. PMID:35830775
  4. Harris WS, Del Gobbo L, Tintle NL. The Omega-3 Index and relative risk for coronary heart disease mortality: Estimation from 10 cohort studies. Atherosclerosis. 2017;262:51-54. PMID:28511049
  5. Harris WS, Luo J, Pottala JV, et al. Red blood cell polyunsaturated fatty acids and mortality in the Women's Health Initiative Memory Study. J Clin Lipidol. 2017;11(1):250-259.e5. PMID:28391893
  6. Bernasconi AA, Wiest MM, Lavie CJ, Milani RV, Laukkanen JA. Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression of Interventional Trials. Mayo Clin Proc. 2021;96(2):304-313. doi:10.1016/j.mayocp.2020.08.034. PMID:32951855
  7. Dinu M, Colombini B, Pagliai G, et al. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis. Eur J Prev Cardiol. 2024;31(15):1863-1875. doi:10.1093/eurjpc/ zwae179. PMID:38869144
  8. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354(9177):447-455. PMID:10465168
  9. Yokoyama M, Origasa H, Matsuzaki M, et al.; JELIS Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients: a randomised open-label, blinded endpoint analysis. Lancet. 2007;369(9567):1090-1098. doi:10.1016/S0140-6736(07)60527-3. PMID:17398308
  10. Bhatt DL, Steg PG, Miller M, et al.; REDUCE-IT Investigators. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019;380(1):11-22. doi:10.1056/NEJMoa1812792. PMID:30415628
  11. Budoff MJ, Bhatt DL, Kinninger A, et al. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial. Eur Heart J. 2020;41(40):3925-3932. doi:10.1093/eurheartj/ehaa652. PMID:32860032
  12. Arabi SM, Bahrami LS, Rahimi R, et al. Omega-3 fatty acids and endothelial function: A GRADE-assessed systematic review and meta-analysis. Eur J Clin Invest. 2024;54(2):e14109. doi:10.1111/eci.14109. PMID:37859571
  13. Oh PC, Koh KK, Sakuma I, et al. Omega-3 fatty acid therapy dose-dependently decreased triglycerides and improved flow-mediated dilation in patients with hypertriglyceridemia. Int J Cardiol. 2014;176(3):696-702. PMID:25147070
  14. Zhang X, Ritonja JA, Zhou N, Chen BE, Li X. Omega-3 Polyunsaturated Fatty Acids Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2022;11(11):e025071. doi:10.1161/JAHA.121.025071. PMID:35647665
  15. Wang T, Zhang X, Zhou N, et al. Association Between Omega-3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose-Response Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2023;12(11):e029512. PMID:37264945
  16. Eslick GD, Howe PRC, Smith C, Priest R, Bensoussan A. Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Int J Cardiol. 2009;136(1):4-16. doi:10.1016/ j.ijcard.2008.03.092. PMID:18774613
  17. Skulas-Ray AC, Kris-Etherton PM, Harris WS, et al. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceride‐ mia. Am J Clin Nutr. 2011;93(2):243-252. doi:10.3945/ajcn.110.003871. PMID:21159789
  18. Skulas-Ray AC, Alaupovic P, Kris-Etherton PM, West SG. Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia. J Clin Lipidol. 2015;9(3):360-367. PMID:26073395
  19. OMEGA-REMODEL — omega-3, ventricular remodeling and fibrosis after myocardial infarction.
  20. GISSI-HF — omega-3 in chronic heart failure.
  21. VITAL — marine omega-3 and primary prevention.
  22. Cochrane, 2020 — omega-3 for primary and secondary prevention of cardiovascular disease.
  23. GISSI-Prevenzione — n-3 supplementation after myocardial infarction and cardiovascular outcomes. PMID 11999724.
  24. Meta-analysis of 38 randomized trials — omega-3 and cardiovascular outcomes. PMID 34505026.

Brain, cognition, children and students

Practical application: brain and cognition and students.

DHA, attention, memory, school performance, ADHD and cognition.

  1. McNamara RK, Carlson SE. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids. 2006;75(4-5):329-349. doi:10.1016/j.plefa.2006.07.010. PMID:16949263
  2. Bazinet RP, Layé S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci. 2014;15(12):771-785. doi:10.1038/nrn3820. PMID:25387473
  3. EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on the substantiation of health claims related to DHA and maintenance of normal brain function. EFSA Journal. 2010;8(10):1734. doi:10.2903/j.efsa.2010.1734.
  4. Tan ZS, Harris WS, Beiser AS, et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology. 2012;78(9):658-664. doi:10.1212/WNL.0b013e318249f6a9. PMID:22371413
  5. Satizabal CL, Himali JJ, Beiser AS, et al. Association of red blood cell omega-3 fatty acids with MRI markers and cognitive function in midlife: The Framingham Heart Study. Neurology. 2022;99(23):e2572- e2582. PMID:36198518
  6. Pottala JV, Yaffe K, Robinson JG, Espeland MA, Wallace R, Harris WS. Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study. Neurology. 2014;82(5):435-442. doi:10.1212/WNL.0000000000000080. PMID:24453077
  7. Schaefer EJ, Bongard V, Beiser AS, et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart Study. Arch Neurol. 2006;63(11):1545-1550. PMID:17101822
  8. Wei BZ, Li L, Dong CW, Tan CC, Xu W. The relationship of omega-3 fatty acids with dementia and cognitive decline: evidence from prospective cohort studies of supplementation, dietary intake and blood markers. Am J Clin Nutr. 2023;117(6):1096-1109. doi:10.1016/j.ajcnut.2023.04.001. PMID:37028557
  9. Witte AV, Kerti L, Hermannstädter HM, et al. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex. 2014;24(11):3059-3068. doi:10.1093/cercor/bht163. PMID:23796946
  10. Liao Y, Xie B, Zhang H, et al. Efficacy of omega-3 PUFAs in depression: a meta-analysis. Transl Psychiatry. 2019;9:190. doi:10.1038/s41398-019-0515-5. PMID:31383846
  11. Wang Y, Lin QW, Zheng PP, Zhang JS, Huang FR. Effect of high ratio of n-6/n-3 PUFAs on depression: a meta-analysis of prospective studies. Front Nutr. 2022;9:889576. doi:10.3389/fnut.2022.889576. PMID:35669073
  12. Guu TW, Mischoulon D, Sarris J, et al. International Society for Nutritional Psychiatry Research practice guidelines for omega-3 fatty acids in the treatment of major depressive disorder. Psychother Psychosom. 2019;88(5):263-273. doi:10.1159/000502652. PMID:31480057
  13. Chang JPC, Su KP, Mondelli V, Pariante CM. Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: a systematic review and meta-analysis of clinical trials and biological studies. Neuropsychopharmacology. 2018;43(3):534-545. doi:10.1038/npp.2017.160. PMID:28741625
  14. Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention- deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2011;50(10):991-1000. PMID:21961774
  15. Widenhorn-Müller K, Schwanda S, Scholz E, Spitzer M, Bode H. Effect of supplementation with long- chain omega-3 polyunsaturated fatty acids on behavior and cognition in children with ADHD: a randomized placebo-controlled intervention trial. Prostaglandins Leukot Essent Fatty Acids. 2014;91(1-2):49-60. PMID:24958525
  16. McNamara RK et al. DHA supplementation, cortical activation and attention in healthy boys.
  17. Sheppard KW, Cheatham CL. Omega-6/omega-3 ratio and executive function in children.
  18. Sheppard KW et al. Fatty acids and executive function in children — replication.
  19. van der Wurff ISM et al. Omega-3 Index, attention and information processing in adolescents.
  20. van der Wurff ISM et al. Food2Learn — randomized trial protocol in adolescents.
  21. Valenzuela R et al. Erythrocyte DHA and academic performance in school leavers.
  22. Åberg MAI et al. Fish consumption and school grades in Swedish adolescents.
  23. Stonehouse W et al. DHA supplementation and cognitive performance.
  24. Bauer I et al. Omega-3 supplementation and cognitive function.
  25. Chang JPC et al. High-dose EPA, baseline EPA status and attention in youths.
  26. Bos DJ et al. Omega-3 supplementation and symptoms of inattention.
  27. Milte CM et al. Erythrocyte EPA+DHA, attention and literacy.
  28. Cooper RE et al. Omega-3 and domain-specific cognition in youths: meta-analysis.
  29. Trebatická J et al. Omega-6/omega-3 ratio change and clinical outcomes in youths.
  30. NHANES analysis — dietary n-6:n-3 ratio and ADHD in children/adolescents.
  31. Red blood cell fatty acid patterns and cognitive functions in adolescents.
  32. Tan KML et al. Omega-3 status and academic performance.
  33. Jackson PA et al. EPA-rich oil and cognition.
  34. Richardson AJ et al. DOLAB — DHA and learning/behaviour.
  35. Richardson AJ et al. DOLAB II.
  36. Gow RV et al. Omega-3 blood levels and ADHD: meta-analysis.
  37. Omega-3 PUFAs for ADHD core symptoms: meta-analysis.
  38. Händel MN et al. PUFA supplementation in ADHD: systematic review and meta-analysis.
  39. Fish oil/DHA supplementation and cognitive function in children.
  40. Adolescent omega-fatty-acid randomized trial: memory and executive attention.
  41. Diet-induced EPA+DHA changes and school performance in Danish children.
  42. Krill oil supplementation and school grades in adolescents.
  43. Plasma n-3 fatty acids and mortality in older adults. PMID 23546563.
  44. Omega-3 Index and incidence of frailty in adults aged 70–84 years. PMID 40740649.
  45. DO-HEALTH — omega-3 and incidence of falls in adults aged 70 years or older. PMID 35136915.

Metabolism, insulin resistance and liver

Practical application: metabolism and liver.

Metabolic syndrome, diabetes, lipids and fatty liver disease.

  1. Albert BB, Derraik JGB, Brennan CM, et al. Higher omega-3 index is associated with increased insulin sensitivity and more favourable metabolic profile in middle-aged overweight men. Sci Rep. 2014;4:6697. doi:10.1038/srep06697. PMID:25331725
  2. Tsitouras PD, Gucciardo F, Salbe AD, Heward C, Harman SM. High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res. 2008;40(3):199-205. doi:10.1055/s-2008-1046759. PMID:18348080
  3. Jang H, Park K. Omega-3 and omega-6 polyunsaturated fatty acids and metabolic syndrome: a systematic review and meta-analysis. Clin Nutr. 2020;39(3):765-773. doi:10.1016/j.clnu.2019.03.032. PMID:31010701
  4. Wang Y, Wang Y, Shehzad Q, et al. Does omega-3 PUFAs supplementation improve metabolic syndrome and related cardiovascular diseases? A systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2024;64(26):9455-9482. doi:10.1080/10408398.2023.2212817. PMID:37222574
  5. Basirat A, Merino-Torres JF. Marine-Based Omega-3 Fatty Acids and Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2025;17(20):3279. doi:10.3390/ nu17203279. PMID:41156531
  6. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542-1556. doi:10.1016/j.jhep.2023.06.003. PMID:37364790
  7. Scorletti E, Byrne CD. Omega-3 fatty acids, hepatic lipid metabolism, and non-alcoholic fatty liver disease. Annu Rev Nutr. 2013;33:231-248. doi:10.1146/annurev-nutr-071812-161230. PMID:23862644
  8. Lee CH, Fu Y, Yang SJ, Chi CC. Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Non- Alcoholic Fatty Liver: A Systematic Review and Meta-Analysis. Nutrients. 2020;12(9):2769. doi:10.3390/ nu12092769. PMID:32932796
  9. Kim SJ, Cho SH, Yun JM. Omega-3 polyunsaturated fatty acids and nonalcoholic fatty liver disease in adults: a meta-analysis of randomized controlled trials. Clin Nutr. 2025;50:164-174. doi:10.1016/ j.clnu.2025.05.013. PMID:40441053
  10. Scorletti E, Bhatia L, McCormick KG, et al. Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the WELCOME study. Hepatology. 2014;60(4):1211-1221. doi:10.1002/hep.27289. PMID:25043514
  11. Scorletti E, West AL, Bhatia L, et al. Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: results from the WELCOME trial. J Hepatol. 2015;63(6):1476-1483. doi:10.1016/j.jhep.2015.07.036. PMID:26272871
  12. Tobin D, Brevik-Andersen M, Qin Y, Innes JK, Calder PC. Evaluation of a High Concentrate Omega-3 for Correcting the Omega-3 Fatty Acid Nutritional Deficiency in Non-Alcoholic Fatty Liver Disease (CONDIN). Nutrients. 2018;10(8):1126. doi:10.3390/nu10081126. PMID:30127297

Athletes, muscle, recovery and joints

Practical application: athletes, professional sport and joints.

Protein synthesis, strength, recovery, DOMS, VO₂ and muscle function.

  1. Smith GI, Atherton P, Reeds DN, Mohammed BS, Rankin D, Rennie MJ, Mittendorfer B. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Am J Clin Nutr. 2011;93(2):402-412. doi:10.3945/ajcn.110.005611. PMID:21159787
  2. Smith GI, Atherton P, Reeds DN, Mohammed BS, Rankin D, Rennie MJ, Mittendorfer B. Omega-3 polyunsaturated fatty acids augment the muscle protein anabolic response to hyperinsulinaemia- hyperaminoacidaemia in healthy young and middle-aged men and women. Clin Sci (Lond). 2011;121(6):267-278. doi:10.1042/CS20100597. PMID:21501117
  3. Therdyothin A, Prokopidis K, Galli F, Witard OC, Isanejad M. The effects of omega-3 polyunsaturated fatty acids on muscle and whole-body protein synthesis: a systematic review and meta-analysis. Nutr Rev. 2025;83(2):e131-e143. PMID:38777807
  4. Rodacki CLN, Rodacki ALF, Pereira G, Naliwaiko K, Coelho I, Pequito D, Fernandes LC. Fish-oil supplementation enhances the effects of strength training in elderly women. Am J Clin Nutr. 2012;95(2):428-436. doi:10.3945/ajcn.111.021915. PMID:22218156
  5. Da Boit M, Sibson R, Sivasubramaniam S, et al. Sex differences in the effect of fish-oil supplementation on the adaptive response to resistance exercise training in older people: a randomized controlled trial. Am J Clin Nutr. 2017;105(1):151-158. doi:10.3945/ajcn.116.140780. PMID:27852617
  6. Brook MS, et al. Omega-3 supplementation during unilateral resistance exercise training in older women: a within-subject and double-blind placebo-controlled trial. Clin Nutr. 2022;41(4):888-898. PMID:34857226
  7. Uchida Y, Tsuji K, Ochi E. Effects of Omega-3 fatty acids supplementation and resistance training on skeletal muscle. Clin Nutr ESPEN. 2024;61:189-196. doi:10.1016/j.clnesp.2024.03.019. PMID:38777432
  8. Kyriakidou Y, Wood C, Ferrier C, Dolci A, Elliott B. The effect of Omega-3 polyunsaturated fatty acid supplementation on exercise-induced muscle damage. J Int Soc Sports Nutr. 2021;18(1):9. doi:10.1186/ s12970-020-00405-1. PMID:33441158
  9. Makaje N, Ruangthai R, Sae-Tan S. Effects of Omega-3 Supplementation on the Delayed Onset Muscle Soreness after Cycling High Intensity Interval Training in Overweight or Obese Males. Clin Nutr ESPEN. 2024. PMID:38841630
  10. Heileson JL, et al. Long-Chain Omega-3 Fatty Acid Supplementation and Exercise-Induced Muscle Damage: EPA or DHA? Med Sci Sports Exerc. 2024. PMID:38051142
  11. Yaghoobi E, Pashaei F, Allsopp GL, et al. Effects of LC n-3 PUFA Supplementation on Muscle Pain, Function, and Damage Markers in Healthy Young to Middle-Aged Adults Following Acute or Chronic Exercise: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2026;18(9):1447. doi:10.3390/nu18091447. PMID:42124047
  12. Żebrowska A, Mizia-Stec K, Mizia M, Gąsior Z, Poprzęcki S. Omega-3 fatty acids supplementation improves endothelial function and maximal oxygen uptake in endurance-trained athletes. Eur J Sport Sci. 2015;15(4):305-314. doi:10.1080/17461391.2014.949310. PMID:25176010
  13. Jäger R, et al. International Society of Sports Nutrition Position Stand: Long-Chain Omega-3 Polyunsaturated Fatty Acids. J Int Soc Sports Nutr. 2025;22(1):2441775. doi:10.1080/15502783.2024.2441775. PMID:39810703
  14. Smith GI, Julliand S, Reeds DN, Sinacore DR, Klein S, Mittendorfer B. Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults. Am J Clin Nutr. 2015;102(1):115-122. doi:10.3945/ajcn.114.105833. PMID:25994567
  15. Cornish SM, et al. Effects of Omega-3 Supplementation Alone and Combined with Resistance Exercise on Skeletal Muscle in Older Adults: a systematic review and meta-analysis. Nutrients. 2022. PMID:35684018
  16. Wang W, Xu Y, Zhou J, Zang Y. Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Clin Rheumatol. 2024;43(8):2479-2488. doi:10.1007/s10067-024-07040-0. PMID:38922552
  17. Lee YH, Bae SC, Song GG. Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis. Arch Med Res. 2012;43(5):356-362. doi:10.1016/j.arcmed.2012.06.011. PMID:22835600
  18. Deng W, et al. Effect of omega-3 polyunsaturated fatty acids supplementation for patients with osteoarthritis: a meta-analysis. J Orthop Surg Res. 2023;18:381. doi:10.1186/s13018-023-03855-w. PMID:37226250
  19. Omega-3 Index in winter endurance athletes.
  20. Omega-3 Index in NCAA football athletes.
  21. Omega-3 Index across NCAA sports.
  22. Elite and world-class Australian athletes — Omega-3 Index in 595 athletes. PMID 42467283.
  23. Omega-3 Index and heart-rate recovery after exercise. PMID 25355484.
  24. DHA, Omega-3 Index e custo de oxigénio no ciclismo em indivíduos treinados. PMID 28338369.
  25. Long-distance runners — 12 weeks of omega-3, Omega-3 Index, running economy and VO₂peak. PMID 36161864.
  26. Elite women's football — DHA and complex reaction time. PMID 24149875.
  27. Competitive football — fish oil added to a recovery drink. PMID 28871832.
  28. Professional rugby — omega-3 supplementation, soreness and maintenance of power. PMID 29985775.
  29. EPA+DHA and recovery after eccentric contractions: strength and joint range of motion. PMID 27085996.
  30. Football — n-3 supplementation during training and anaerobic/intermittent capacity. PMID 28387540.
  31. Football — repetitive heading and biomarkers of axonal injury. PMID 30233810.
  32. NCAA football — omega-3, Omega-3 Index, AA:EPA and neurofilament light. PMID 34579748.
  33. NCAA football — dose-dependent Omega-3 Index response to DHA. PMID 36728325.
  34. Professional women's rugby — changes in the Omega-3 Index and AA:EPA ratio. PMID 38648883.

Skin, pregnancy and early years

Practical application: skin, women's health and vision and retina.

Skin, photoprotection, pregnancy, prematurity and child neurodevelopment.

  1. Handeland K, Wakeman M, Burri L. Krill oil supplementation improves transepidermal water loss, hydration and elasticity of the skin in healthy adults: results from two randomized, double-blind, placebo- controlled, dose-finding pilot studies. J Cosmet Dermatol. 2024;23(12):4285-4294. doi:10.1111/jocd.16513. PMID:39169540
  2. Pilkington SM, Rhodes LE, Al-Aasswad NMI, et al. Impact of EPA ingestion on COX- and LOX- mediated eicosanoid synthesis in skin with and without a pro-inflammatory UVR challenge: report of a randomised controlled study in humans. Mol Nutr Food Res. 2014;58(3):580-590. doi:10.1002/ mnfr.201300405. PMID:24311515
  3. Rhodes LE, O'Farrell S, Jackson MJ, Friedmann PS. Dietary fish-oil supplementation in humans reduces UVB-erythemal sensitivity but increases epidermal lipid peroxidation. J Invest Dermatol. 1994;103(2):151-154. doi:10.1111/1523-1747.ep12392604. PMID:8040603
  4. Pilkington SM, Massey KA, Bennett SP, et al. Randomized controlled trial of oral omega-3 PUFA in solar- simulated radiation-induced suppression of human cutaneous immune responses. Am J Clin Nutr. 2013;97(3):646-652. doi:10.3945/ajcn.112.049494. PMID:23364005
  5. Rhodes LE, Durham BH, Fraser WD, Friedmann PS. Dietary fish oil reduces basal and ultraviolet B- generated PGE2 levels in skin and increases the threshold to provocation of polymorphic light eruption. J Invest Dermatol. 1995;105(4):532-535. PMID:7561154
  6. Rhodes LE, Shahbakhti H, Azurdia RM, et al. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans: an assessment of early genotoxic markers. Carcinogenesis. 2003;24(5):919-925. PMID:12771037
  7. Cetin I, Carlson SE, Burden C, et al. Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth. Am J Obstet Gynecol MFM. 2024;6(2):101251. doi:10.1016/j.ajogmf.2023.101251. PMID:38070679
  8. Bergmann RL, Haschke-Becher E, Klassen-Wigger P, et al. Supplementation with 200 mg/day DHA from mid-pregnancy through lactation improves the DHA status of mothers with a habitually low fish intake and of their infants. Ann Nutr Metab. 2008;52(2):157-166. doi:10.1159/000129651. PMID:18446020
  9. Best KP, Gibson RA, Makrides M. ISSFAL statement number 7: Omega-3 fatty acids during pregnancy to reduce preterm birth. Prostaglandins Leukot Essent Fatty Acids. 2022;186:102495. doi:10.1016/ j.plefa.2022.102495. PMID:36228573
  10. Makrides M, Best K, Yelland L, et al. A randomized trial of prenatal n-3 fatty acid supplementation and preterm delivery. N Engl J Med. 2019;381(11):1035-1045. doi:10.1056/NEJMoa1816832. PMID:31509674
  11. Middleton P, Gomersall JC, Gould JF, Shepherd E, Olsen SF, Makrides M. Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst Rev. 2018;11:CD003402. doi:10.1002/14651858.CD003402.pub3. PMID:30480773
  12. Best KP, Northcott C, Simmonds LA, et al. The early implementation phase of the Omega-3 Test-and- Treat Program for reducing the risk of preterm birth, South Australia, 2021-22: an implementation evaluation study. Med J Aust. 2025. doi:10.5694/mja2.70101.
  13. Jensen CL, Voigt RG, Prager TC, et al. Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. Am J Clin Nutr. 2005;82(1):125-132. doi:10.1093/ ajcn.82.1.125. PMID:16002810
  14. Jensen CL, Voigt RG, Llorente AM, et al. Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants. J Pediatr. 2010;157(6):900-905. PMID:20655543
  15. Nevins JEH, Donovan SM, Snetselaar L, et al. Omega-3 fatty acid dietary supplements consumed during pregnancy and lactation and child neurodevelopment: a systematic review. J Nutr. 2021;151(11):3483-3494. doi:10.1093/jn/nxab238. PMID:34383914
  16. ORIP — identifying women who may benefit from a higher omega-3 dose during pregnancy. PMID 37068907.
  17. Omega-3 and polycystic ovary syndrome — recent review. PMID 39275277.
  18. Omega-3 in women with polycystic ovary syndrome — clinical data. PMID 29580250.
  19. Omega-3 supplementation and dysmenorrhea severity. PMID 22261128.
  20. Omega-3 in adolescent dysmenorrhea. PMID 8623866.Related scientific study
  21. Clinical trial — omega-3 and dry-eye parameters/Meibomian gland dysfunction. PMID 27442314.
  22. AREDS report 23 — EPA+DHA intake and incidence of age-related macular degeneration. PMID 18779490.

From evidence to application

After reviewing the studies, see how the evidence was organised in the Omega-3 Science Library presentations or follow the integrated view of the book The Science of Balance.